'We Plan To Stop COVID-19 At Its Point Of Entry': University Works With Houston Biotech Company On Nasal Vaccine
A Houston-based biotech company developing techniques to deliver vaccines via nasal spray for viruses like COVID-19 has entered an exclusive license option agreement with the University of Houston.



